Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,167.00p
   
  • Change Today:
      25.00p
  • 52 Week High: 1,179.00
  • 52 Week Low: 576.50
  • Currency: UK Pounds
  • Shares Issued: 124.77m
  • Volume: 114,228
  • Market Cap: £1,456.06m
  • RiskGrade: 314

Indivior flags delay to FDA review of Sublocade label change

By Josh White

Date: Wednesday 12 Feb 2025

LONDON (ShareCast) - (Sharecast News) - Indivior announced a delay in the US Food and Drug Administration's (FDA) final review of proposed label changes for its 'Sublocade', or buprenorphine extended-release, injection on Wednesday.
The company was expecting a decision by 7 February, as per the Prescription Drug User Fee Act (PDUFA) timeline.

It said on Wednesday that the FDA informed the company on 11 February that there were no outstanding issues following acceptance of the proposed label, which includes a rapid initiation protocol and alternative injection sites.

However, the final review process has been delayed.

The company did not provide a revised timeline for approval but said it would issue further updates as appropriate.

At 0813 GMT, shares in Indivior were up 6.47% at 814.5p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Indivior Market Data

Currency UK Pounds
Share Price 1,167.00p
Change Today 25.00p
% Change 2.19 %
52 Week High 1,179.00
52 Week Low 576.50
Volume 114,228
Shares Issued 124.77m
Market Cap £1,456.06m
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.95% below the market average54.95% below the market average54.95% below the market average54.95% below the market average54.95% below the market average
43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average
Price Trend
68.01% above the market average68.01% above the market average68.01% above the market average68.01% above the market average68.01% above the market average
65.22% above the sector average65.22% above the sector average65.22% above the sector average65.22% above the sector average65.22% above the sector average
Income Not Available
Growth
52.24% above the market average52.24% above the market average52.24% above the market average52.24% above the market average52.24% above the market average
12.50% above the sector average12.50% above the sector average12.50% above the sector average12.50% above the sector average12.50% above the sector average

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for 14-Jul-2025

Time Volume / Share Price
16:35 248 @ 1,167.00p
16:35 662 @ 1,167.00p
16:35 247 @ 1,167.00p
16:35 341 @ 1,167.00p
16:35 34,450 @ 1,167.00p

Indivior Key Personnel

CEO Mark Crossley
Chair David E. Wheadon

Top of Page